Ingevity (NYSE:NGVT) Hits New 1-Year High – Should You Buy?

Ingevity Corporation (NYSE:NGVTGet Free Report)’s share price reached a new 52-week high on Friday . The company traded as high as $77.62 and last traded at $76.46, with a volume of 68391 shares traded. The stock had previously closed at $75.26.

Wall Street Analysts Forecast Growth

NGVT has been the topic of several recent analyst reports. Wells Fargo & Company increased their target price on Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Jefferies Financial Group restated a “buy” rating and issued a $82.00 price objective on shares of Ingevity in a research note on Thursday, February 26th. BMO Capital Markets reiterated an “outperform” rating and set a $83.00 target price on shares of Ingevity in a research note on Monday, March 2nd. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research report on Tuesday. Finally, Wall Street Zen downgraded shares of Ingevity from a “buy” rating to a “hold” rating in a research report on Saturday, April 4th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $80.00.

Check Out Our Latest Research Report on NGVT

Ingevity Price Performance

The company has a debt-to-equity ratio of 39.10, a quick ratio of 0.79 and a current ratio of 1.33. The firm has a market cap of $2.70 billion, a price-to-earnings ratio of -16.43 and a beta of 1.27. The company’s fifty day moving average is $70.88 and its two-hundred day moving average is $62.83.

Ingevity (NYSE:NGVTGet Free Report) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by ($0.16). The firm had revenue of $255.10 million for the quarter, compared to analysts’ expectations of $257.27 million. Ingevity had a positive return on equity of 126.25% and a negative net margin of 13.51%.The business’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period last year, the firm earned $0.95 EPS. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. Equities research analysts forecast that Ingevity Corporation will post 5.05 EPS for the current year.

Institutional Investors Weigh In On Ingevity

A number of institutional investors have recently modified their holdings of the business. Global Retirement Partners LLC acquired a new position in Ingevity during the 4th quarter valued at about $27,000. Oakworth Capital Inc. acquired a new stake in Ingevity during the third quarter valued at approximately $28,000. Meeder Asset Management Inc. acquired a new stake in Ingevity during the fourth quarter valued at approximately $33,000. Kestra Advisory Services LLC acquired a new stake in Ingevity during the fourth quarter valued at approximately $47,000. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Ingevity by 85.8% during the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after acquiring an additional 387 shares during the period. Institutional investors own 91.59% of the company’s stock.

Ingevity Company Profile

(Get Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Recommended Stories

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.